Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase‐related protein in vitiligo
暂无分享,去创建一个
J. Park | K. Jimbow | J S Park | H. Chen | P. Thomas | K Jimbow | H Chen | P D Thomas | Thomas Pd | J-S Park | Park Js
[1] P. Nowell,et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. , 1985, Cancer research.
[2] J. Riordan,et al. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. , 1994, The Journal of biological chemistry.
[3] P. H. Cameron,et al. Association of folding intermediates of glycoproteins with calnexin during protein maturation , 1993, Nature.
[4] K. Steel,et al. Genetics and molecular biology of mouse pigmentation. , 1994, Pigment cell research.
[5] R. Snell,et al. Vitiligo and sympathectomy. The effect of sympathectomy and alpha- melanocyte stimulating hormone. , 1966, Archives of dermatology.
[6] G. Imokawa,et al. Tyrosinase Stabilization by Tyrp1 (the brown Locus Protein)* , 1998, The Journal of Biological Chemistry.
[7] K. Jimbow. VITILIGO: Therapeutic Advances , 1998 .
[8] K. Jimbow,et al. Induction of melanogenesis during the various melanoma growth phases and the role of tyrosinase, lysosome-associated membrane proteins, and p90 calnexin in the melanogenesis cascade. , 1996, Journal of Investigative Dermatology Symposium Proceedings.
[9] J. Park,et al. Promotion of tyrosinase folding in COS 7 cells by calnexin. , 1999, Journal of biochemistry.
[10] M. Eisinger,et al. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Matteson,et al. Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Comparison of their deduced amino acid sequences. , 1988, The Journal of biological chemistry.
[12] G. Imokawa,et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. , 1994, The EMBO journal.
[13] J. Wood,et al. Low catalase levels in the epidermis of patients with vitiligo. , 1991, The Journal of investigative dermatology.
[14] Gaze,et al. Serum selenium levels and blood glutathione peroxidase activities in vitiligo , 1999, The British journal of dermatology.
[15] R. Jaenisch,et al. Phenotypic rescue of mutant brown melanocytes by a retrovirus carrying a wild-type tyrosinase-related protein gene. , 1990, Development.
[16] I. Jackson,et al. Light is a dominant mouse mutation resulting in premature cell death , 1992, Nature Genetics.
[17] I. Jackson,et al. Functional properties of cloned melanogenic proteins. , 1992, Pigment cell research.
[18] Hedley,et al. Vitiligo melanocytes in long‐term culture show normal constitutive and cytokine‐induced expression of intercellular adhesion molecule‐1 and major histocompatibility complex class I and class II molecules , 1998, The British journal of dermatology.
[19] E. Medrano,et al. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. , 1991, The Journal of investigative dermatology.
[20] V. Hearing,et al. Human tyrosinase related protein‐1 (TRP‐1) does not function as a DHICA oxidase activity in contrast to murine TRP‐1 , 1998, Experimental dermatology.
[21] W. Westerhof,et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. , 1993, The Journal of investigative dermatology.
[22] I. Jackson,et al. A second tyrosinase‐related protein, TRP‐2, is a melanogenic enzyme termed DOPAchrome tautomerase. , 1992, The EMBO journal.
[23] S. Passi,et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. , 1997, The Journal of investigative dermatology.
[24] S. Shibahara,et al. Structural organization of the human heme oxygenase gene and the function of its promoter. , 1989, European journal of biochemistry.
[25] A. Houghton,et al. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75 , 1995, The Journal of cell biology.
[26] G. Naughton,et al. Expression of vitiligo antigen on a revertant line of hamster melanoma cells. , 1984, The Journal of investigative dermatology.
[27] I. Jackson,et al. Characterization of TRP-1 mRNA levels in dominant and recessive mutations at the mouse brown (b) locus. , 1990, Genetics.
[28] A. Houghton,et al. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product , 1990, The Journal of experimental medicine.
[29] M. Brenner,et al. Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum. , 1994, International immunology.
[30] A. P. Kelly,et al. T cell profiles in vitiligo. , 1986, Journal of the American Academy of Dermatology.
[31] J. Sawatzki,et al. In vivo evidence for compromised phenylalanine metabolism in vitiligo. , 1998, Biochemical and biophysical research communications.
[32] I. Wada,et al. Chaperone function of calnexin for the folding intermediate of gp80, the major secretory protein in MDCK cells. Regulation by redox state and ATP. , 1994, The Journal of biological chemistry.
[33] R. Boissy,et al. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo. , 1995, The American journal of pathology.
[34] K. Jimbow,et al. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. , 1994, Cancer research.
[35] K. Jimbow,et al. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1. , 1994, Experimental cell research.
[36] J N Rodríguez-López,et al. Tyrosinase: a comprehensive review of its mechanism. , 1995, Biochimica et biophysica acta.
[37] M. Lee,et al. Coordinated mRNA and protein expression of human LAMP-1 in induction of melanogenesis after UV-B exposure and co-transfection of human tyrosinase and TRP-1 cDNAs. , 1994, Pigment cell research.
[38] M. Lee,et al. Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas. , 1994, The Journal of investigative dermatology.
[39] T. Fitzpatrick,et al. Ultrastructural investigation of autophagocytosis of melanosomes and programmed death of melanocytes in White Leghorn feathers: a study of morphogenetic events leading to hypomelanosis. , 1974, Developmental biology.
[40] V. Hearing,et al. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. , 1991, The Journal of biological chemistry.
[41] V. Hearing,et al. Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] K. Jimbow,et al. A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes. , 1993, British Journal of Cancer.
[43] D. Bennett,et al. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. , 1989, Development.
[44] N. Copeland,et al. A second tyrosinase‐related protein, TRP‐2, maps to and is mutated at the mouse slaty locus. , 1992, The EMBO journal.
[45] K. Jimbow,et al. Identification of a cDNA coding for a Ca(2+)-binding phosphoprotein (p90), calnexin, on melanosomes in normal and malignant human melanocytes. , 1993, Experimental cell research.
[46] K. Jimbow,et al. Molecular Control of Melanogenesis in Malignant Melanoma: Functional Assessment of Tyrosinase and Lamp Gene Families by UV Exposure and Gene Co‐Transfection, and Cloning of a cDNA Encoding Calnexin, A Possible Melanogenesis “Chaperone” , 1994, The Journal of dermatology.
[47] Ikuo WadaSO,et al. Chaperone Function of Calnexin for the Folding Intermediate of gp 80 , the Major Secretory Protein in MDCK Cells , 2001 .
[48] E Panzig,et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. , 1999, The journal of investigative dermatology. Symposium proceedings.